Attitudes toward genetic testing
|
|
- Eleanore Curtis
- 8 years ago
- Views:
Transcription
1 DOI /jbcpp J Basic Clin Physiol Pharmacol 2013; 24(3): Mini Review Natali Idan, Zippora Brownstein, Shaked Shivatzki and Karen B. Avraham* Advances in genetic diagnostics for hereditary hearing loss Abstract: Hereditary hearing loss affects a significant proportion of the hearing impaired, with genetic mutations estimated to be responsible for its etiology in over 50% of this population. The methods for molecular diagnostics are changing as a result of the transition from linkage analysis to next generation sequencing to identify the genes responsible for hearing loss in affected families. In this review, we summarize the attitudes of the hearing impaired towards genetic testing, the latest techniques for identifying mutations, and provide a comprehensive list of the mutations found in the Israeli Jewish hearingimpaired population. Keywords: deafness; exome sequencing; massively parallel sequencing; mutations; targeted capture. *Corresponding author: Prof. Karen B. Avraham, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel, Phone: , Fax: , karena@post.tau.ac.il Natali Idan, Zippora Brownstein and Shaked Shivatzki: Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel Genetics of hearing loss Genetic testing and counseling are the cornerstones of medical genetics, providing crucial answers for patients with hereditary diseases. The considerations and details differ, depending on the disease, but the questions remain the same: What are the recurrence rates, risks, benefits, and possible consequences of each available option? For hereditary hearing loss (HL), a sensorineural disorder that is compatible with life, many of the questions remain the same, but the approach differs, depending on whether the parents are deaf or hearing, the age of onset, and whether the HL is isolated or part of a syndrome. Sensorineural HL is the most common sensory disorder, affecting 4% of the population before the age of 45 [1]. This form of HL is caused by various defects in the inner ear and associated nerve fibers, and the onset ranges from birth through childhood to late adulthood. HL can be due to genetic mutations, a result of exposure to environmental factors, or a combination of both. Most early-onset HL disorders are genetic [2], and a major portion of late-onset HL is as well or at least has genetic factors contributing to a multifactorial etiology [3]. Hereditary HL is a heterogeneous condition, with more than 700 forms of deafness associated with other clinical abnormalities (syndromic HL, SHL) (Online Mendelian Inheritance in Man; Over 100 loci have been linked to dominant, recessive, and X-linked forms of nonsyndromic HL (NSHL), and over 60 genes have been identified, some of which are associated with both recessive and dominant forms of deafness, as well as SHL [4]. Attitudes toward genetic testing A large effort has been made in the past two decades to discover the genes involved in hereditary HL. Although the principles defining the function of the cochlea, the mammalian auditory organ, have been recognized for some time, knowledge about the molecular mechanisms of the auditory system has only recently come to light [5]. Revealing the genetic basis of hereditary HL is crucial for patients eager to know the cause of their HL. Known etiology enables preimplantation decisions or prenatal diagnosis in order to prevent recurrence. In addition, it is important in promoting the understanding of the molecular basis of HL and the auditory system, which may facilitate new methods of treatment. In recent years, deaf individuals attitudes and perceptions of genetic testing for deafness have shifted toward greater personal interest [6, 7]. Deaf individuals and parents of deaf children, in general, are interested in pursuing genetic testing [8, 9]. However, the reasons and motivations behind this interest vary. It is multifaceted, with cultural considerations playing a major role. The most important reasons for pursuing genetic testing
2 166 Idan et al.: Genetic diagnostics for hereditary hearing loss are to understand the cause of the HL to determine if it is genetic in origin and to evaluate what might be the consequences for other family members. In some cases, patients also want to help advance research, due to an interest in long-term solutions such as prevention in future family members, and advanced rehabilitation and therapeutics based on research outcome [7, 10, 11]. However, genetic testing for deafness is complex for both scientific and social reasons, which introduces complexity into genetic counseling as well. The scientific complexity is derived from the underlying etiological and genetic heterogeneity of deafness and the limitations in the past to conduct a comprehensive genetic test of all deafness genes for each deaf individual as a routine in the clinic. However, targeted capture and next-generation sequencing (NGS), also known as massively parallel sequencing and deep sequencing, of all known deafness genes [12, 13], and whole exome sequencing [14] is now being performed in research as well as in private laboratories, yielding impressive results. These new technologies may change the face of genetic diagnosis for HL, although they bring new challenges. Interpreting and analyzing the NGS test results are one of the obstacles that have to be faced in order to increase the portion of solved cases. The social complexity stems from diverse perceptions and beliefs of the deaf in different societies and cultures. Deafness is not a life-threatening illness. Moreover, many individuals do not consider it a medical condition or a disorder that needs to be treated, but as a nonmedical trait that does not require medical intervention [15]. A complicated picture of deaf individuals reasons for genetic testing has been drawn, where cultural affiliation appears to play an important role in constructing their motivations for testing [10, 16]. Individuals who associate with the Deaf Community, a community that has developed its own social beliefs, behavior, art, literature, history, values, and institutions, are less likely to endorse genetic testing at birth, compared to individuals with equal involvement in both the deaf and hearing communities [17]. Members of the Deaf Community tend to believe that genetic testing for HL would have a negative effect on their community; they have no preference regarding the hearing status of their children and therefore are not interested in prenatal diagnosis for HL. They are also more likely to feel that termination of pregnancy based on hearing status should be illegal [18]. A small percentage polled would consider termination of pregnancy if the fetus was found to be hearing [19]. Others, who are culturally associated with the hearing community, would see HL as a medical condition, would support prenatal diagnosis, and would consider a termination of pregnancy [18, 20]. For some of them, as well as for the growing elderly population, finding ways to cure or improve hearing is essential. Molecular diagnostics for deafness-causing genes Worldwide, the most frequent causative genes for HL are GJB2, SLC26A4, MYO15A, OTOF, CDH23, and TMC1, most of which are large genes with many deafness-causing mutations in each. Because of the size of the genes and the cost of Sanger sequencing, until recently, only the known mutations were screened in clinics, based on relevance according to ethnic origin and HL phenotype. Searching for new genes or mutations was performed mostly in research laboratories, using linkage analysis followed by Sanger sequencing of the coding regions of each candidate gene in a critical interval. The genes were sequenced one by one after ranking them on the basis of hypotheses about gene function or expression patterns. More than 60 genes were found to be associated with human deafness in this way, but this technique, both time- and cost-consuming, was not optimal as it did not allow for examination of a large number of genes simultaneously. It has been difficult, if not impossible, to offer clinically useful screening for each of the 64 genes currently implicated in NSHL. Recent advances in technology, using NGS, have made it possible to rapidly and cost-effectively sequence all the genes of interest, including the noncoding regions. NGS is changing the face of gene identification and is making it possible to screen for mutations in hundreds of genes, allowing one to provide precise information about the genetic cause and the recurrence risk and offer precise treatment [21]. For example, identification of individuals with mutations in CACNA1D, who are usually initially misdiagnosed with NSHL, should undergo regular cardiological care to avoid cardiac complications that are part of SANDD, a syndrome associated with sinoatrial node dysfunction and deafness [22]. In the Middle East, as in most other regions in the world, the most common gene involved in HL is GJB2, responsible for 27% of congenital HL among Israeli Jews [23] and 14% among Palestinian Arabs [24]. Therefore, in most clinics, the routine test for each deaf individual includes restriction enzyme analysis of the most common mutations in this gene and, occasionally, sequencing of
3 Idan et al.: Genetic diagnostics for hereditary hearing loss 167 Table 1 Mutations for HL found in the Jewish population. Gene RefSeq ID Inheritance Name of mutation a cdna location Origin Phenotype References CDH23 NM_ Recessive V2635F c.7903g > T Algeria NSHL [12] GJB2 NM_ Recessive IVS1+1 G to A c.-3172g > A Iraq NSHL [23] Recessive 35delG c.35del All NSHL [34] Recessive 51del12insA c.51del12insa Buchara NSHL [34] Recessive W24X c.72g > A Buchara NSHL [23] Recessive V27I+E114G c.79g > A+341A > G Ashkenazi NSHL Personal communication Recessive R32C c.94c > T Ashkenazi NSHL [23] Recessive M34T c.101t > G Ashkenazi NSHL Personal communication Recessive V37I c.109g > A Ashkenazi NSHL [23] Recessive 167delT c.167del Ashkenazi, Syria NSHL [35] Recessive L90P c.269t > C Iraq NSHL [23] Recessive R127H c.380g > A India NSHL Personal communication Recessive W134R c.400t > A Iraq NSHL Personal communication Recessive V153I c.457g > A Tunisia NSHL Personal communication Dominant R75Q c.224g > A Ashkenazi NSHL Personal communication GJB6 NM_ Recessive 342kb del(gjb6-d13s1830) 342kb del(gjb6-d13s1830) Ashkenazi NSHL [25] MYO3A NM_ Recessive 1777(-12)G > A c.1777(-12)g > A Iraq NSHL [27] Recessive 732(-2)A > G c.732(-2)a > G Iraq NSHL [27] Recessive Y1042X c.3126t > G Iraq NSHL [27] MYO15A NM_ Recessive 373delCG c.373_374del Ashkenazi NSHL [12] Recessive R2728H c.8183g > A Ashkenazi NSHL [12] PCDH15 NM_ Recessive R245X c.733c > T Ashkenazi USH1F [26] POU3F4 NM_ X-linked Q79X c.235c > T Ashkenazi NSHL, Mondini [33] X-linked 853delAT c.853_854del Bulgaria NSHL, Mondini [33] POU4F3 NM_ Dominant 884del8 c.884_891del Libya NSHL [30] SLC26A4 NM_ Recessive InsT c.1458_1459inst Iran NSHL, EVA b [28] SYNE4 NM_ Recessive 228delAT c.228_229del Iraq NSHL [32] TECTA NM_ Dominant T1866M c.5497c > T Turkey NSHL [12] TJP2 NM_ Dominant Inverted duplication Whole gene Tunisia NSHL [31] TMC1 NM_ Recessive R389X c.1165c > T Morocco NSHL [12] Recessive W404R c.1210t > C Morocco NSHL [12] Recessive R604X c.1810c > T Morocco NSHL [12] Recessive S647P c.1939t > C Morocco NSHL [12] USH1C NM_ Recessive InsC c.238_239insc Ashkenazi USH1C [23] WFS1 NM_ Dominant E864K c.2590g > A Ashkenazi NSHL [12] a The review aims to bring information to clinicians to use routinely in the clinic; therefore, we have referred to the mutations by their common names. b EVA, enlarged vestibular aqueduct.
4 168 Idan et al.: Genetic diagnostics for hereditary hearing loss Figure 1 Representative family with hereditary HL evaluated for genetic diagnosis and counseling. A c.7903g > T mutation was identified in the CDH23 gene encoding the cadherin 23 protein, predicted to lead to a p.v2635f missense mutation, by deep sequencing [12]. (A) The congenital HL is inherited in a recessive mode. (B) Representative pure-tone audiogram from an affected individual with severe to profound HL. Rt, right; Lt, left; AC, air conduction; BC, bone conduction; NR, no response. (C) The mutation was validated by Sanger sequencing, demonstrated in a chromatogram. (D) Residue V2635 in ectodomain 25 of cadherin 23 is buried in the protein core, and the evolutionary conservation analysis shows that it is conserved (ConSurf grade of 7, consurf.tau.ac.il/). The mutation V2635F appears to cause a significant change from a hydrophobic residue of medium size to phenylalanine, which is aromatic, rigid, and much larger. (E) Cadherin 23, along with protocadherin 15, is expressed in the tip links of the stereocilia [36]. the single coding exon of GJB2. The other deafness genes that were known in the Middle East prior to the deep sequencing era included mutations in eight genes for HL in the Israeli Jewish population, which were identified over a period of more than 15 years: GJB6 [25], PCDH15 [26], USH1C (harmonin) [23], MYO3A [27], SLC26A4 [28], LOXHD1 [29], POU4F3 [30], and the inverted duplication of TJP2 [31]. Because most of these genes were found only in one extended family, screening for them was not practical. Only the known mutations in these genes are routinely tested in the clinic, and then only if relevant to a specific ethnic group, mode of inheritance, and type of HL. These routine clinical tests miss other mutations in the known genes and potential new deafness genes, which are most likely the cause of deafness in two-thirds of patients with hereditary HL that remain unsolved with respect to etiology in the Middle East [12] and worldwide. Advances in gene discovery due to NGS Recent experiments, using NGS, added six genes to the list in a short period of time, including CDH23, MYO15A, WFS1, and TECTA [12], SYNE4 [32], and POU3F4 [33]. The genes and mutations involved in HL in the Israeli Jewish population known to date are listed in Table 1. NGS has
5 Idan et al.: Genetic diagnostics for hereditary hearing loss 169 proven to be the optimal genetic diagnostic approach to identify deafness mutations (Figure 1). In addition to the immediate consequences of genetic counseling and guiding clinical decisions, identification of the causative genes is the basis for understanding auditory mechanisms, which, in turn, paves the way not only for successful rehabilitation, but in the future, perhaps for therapeutics as well. Initial steps toward therapy have already been taken and show promising results. In vitro induction of new hair cells and partial recovery of hearing in ears damaged by noise trauma when Notch signaling was inhibited suggests a method to replace lost hair cells by pharmacological inhibition of Notch [37]. Hearing and vestibular function were rescued in a mouse model for Usher syndrome with an antisense oligonucleotide that corrects defective pre-mrna splicing of transcripts from the USH1C gene with the c.216g > A mutation [38]. The optimal approaches to alleviating HL may depend on identifying the genes underlying deafness. In conclusion, the discovery of all deafness genes is now more feasible than ever. A change of concept is about to occur regarding the routine molecular testing for HL, with comprehensive multigene testing likely to become more commonplace. Moreover, identifying all genes involved in deafness might facilitate a greater understanding of auditory complexity. Acknowledgments: We are indebted to the families and physicians who have contributed to our research over the years, allowing us to determine the genetic basis for hearing impairment in Israel. Research in the Karen Avraham laboratory is supported by the National Institutes of Health (NIDCD) R01DC011835, I-CORE Gene Regulation in Complex Human Disease Center No. 41/11, Israel Science Foundation 1320/11, Human Frontier Science Program RGP0012/2012, and the Hedrich Charitable Trust. We thank Maya Shushan and Nir Ben-Tal for the Consurf analysis. Conflict of interest statement Authors conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication. Research funding: None declared. Employment or leadership: None declared. Honorarium: None declared. Received May 10, 2013; accepted August 8, 2013 References 1. Morton CC, Nance WE. Newborn hearing screening a silent revolution. N Engl J Med 2006;354: Nance WE. The genetics of deafness. Ment Retard Dev Disabil Res Rev 2003;9: Bovo R, Ciorba A, Martini A. Environmental and genetic factors in age-related hearing impairment. Aging Clin Exp Res 2011;23: Van Camp G, Smith RJ. Hereditary Hearing Loss Homepage. Available at: Accessed: July Richardson GP, de Monvel JB, Petit C. How the genetics of deafness illuminates auditory physiology. Annu Rev Physiol 2011;73: Dagan O, Hochner H, Levi H, Raas-Rothschild A, Sagi M. Genetic testing for hearing loss: different motivations for the same outcome. Am J Med Genet 2002;113: Withrow KA, Tracy KA, Burton SK, Norris VW, Maes HH, Arnos KS, et al. Impact of genetic advances and testing for hearing loss: results from a national consumer survey. Am J Med Genet A 2009;149A: Brunger JW, Murray GS, O Riordan M, Matthews AL, Smith RJ, Robin NH. Parental attitudes toward genetic testing for pediatric deafness. Am J Hum Genet 2000;67: Parker MJ, Fortnum HM, Young ID, Davis AC. Genetics and deafness: what do families want? J Med Genet 2000;37:E Boudreault P, Baldwin EE, Fox M, Dutton L, Tullis L, Linden J, et al. Deaf adults reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study. J Deaf Stud Deaf Educ 2010;15: Burton SK, Withrow K, Arnos KS, Kalfoglou AL, Pandya A. A focus group study of consumer attitudes toward genetic testing and newborn screening for deafness. Genet Med 2006;8: Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A, et al. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 2011;12:R Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J, 2nd, Scherer S, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 2010;107: Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W, et al. Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 2010;87: Robertson JA. Extending preimplantation genetic diagnosis: the ethical debate. Ethical issues in new uses of preimplantation genetic diagnosis. Hum Reprod 2003;18:
6 170 Idan et al.: Genetic diagnostics for hereditary hearing loss 16. Middleton A, Hewison J, Mueller RF. A pilot study of attitudes of deaf and hearing parents towards issues surrounding genetic testing for deafness. Am J Hum Genet 1997;61:A Taneja PR, Pandya A, Foley DL, Nicely LV, Arnos KS. Attitudes of deaf individuals towards genetic testing. Am J Med Genet A 2004;130A: Stern SJ, Arnos KS, Murrelle L, Welch KO, Nance WE, Pandya A. Attitudes of deaf and hard of hearing subjects towards genetic testing and prenatal diagnosis of hearing loss. J Med Genet 2002;39: Middleton A, Hewison J, Mueller R. Prenatal diagnosis for inherited deafness what is the potential demand? J Genet Couns 2001;10: Arnos KS, Israel J, Cunningham M. Genetic counseling of the deaf. Medical and cultural considerations. Ann N Y Acad Sci 1991;630: Rehm HL. Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 2013;14: Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nurnberg G, et al. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci 2011;14: Brownstein Z, Avraham KB. Deafness genes in Israel: implications for diagnostics in the clinic. Pediatr Res 2009;66: Shahin H, Walsh T, Sobe T, Lynch E, King MC, Avraham KB, et al. Genetics of congenital deafness in the Palestinian population: multiple connexin 26 alleles with shared origins in the Middle East. Hum Genet 2002;110: Lerer I, Sagi M, Ben-Neriah Z, Wang T, Levi H, Abeliovich D. A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: a novel founder mutation in Ashkenazi Jews. Hum Mutat 2001;18: Ben-Yosef T, Ness SL, Madeo AC, Bar-Lev A, Wolfman JH, Ahmed ZM, et al. A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. N Engl J Med 2003;348: Walsh T, Walsh V, Vreugde S, Hertzano R, Shahin H, Haika S, et al. From flies eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci USA 2002;99: Brownstein ZN, Dror AA, Gilony D, Migirov L, Hirschberg K, Avraham KB. A novel SLC26A4 (PDS) deafness mutation retained in the endoplasmic reticulum. Arch Otolaryngol Head Neck Surg 2008;134: Edvardson S, Jalas C, Shaag A, Zenvirt S, Landau C, Lerer I, et al. A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews. Am J Med Genet A 2011;155: Vahava O, Morell R, Lynch ED, Weiss S, Kagan ME, Ahituv N, et al. Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 1998;279: Walsh T, Pierce SB, Lenz DR, Brownstein Z, Dagan-Rosenfeld O, Shahin H, et al. Genomic duplication and overexpression of TJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51. Am J Hum Genet 2010;87: Horn HF, Brownstein Z, Lenz DR, Shivatzki S, Dror AA, Dagan- Rosenfeld O, et al. The LINC complex is essential for hearing. J Clin Invest 2013;123: Parzefall T, Shivatzki S, Lenz DR, Rathkolb B, Ushakov K, Karfunkel D, et al. Cytoplasmic mislocalization of POU3F4 due to novel mutations leads to deafness in humans and mice. Hum Mutat 2013;34: Sobe T, Vreugde S, Shahin H, Berlin M, Davis N, Kanaan M, et al. The prevalence and expression of inherited connexin 26 mutations associated with nonsyndromic hearing loss in the Israeli population. Hum Genet 2000;106: Sobe T, Erlich P, Berry A, Korostichevsky M, Vreugde S, Avraham KB, et al. High frequency of the deafness-associated 167delT mutation in the connexin 26 (GJB2) gene in Israeli Ashkenazim. Am J Med Genet 1999;86: Kazmierczak P, Sakaguchi H, Tokita J, Wilson-Kubalek EM, Milligan RA, Muller U, et al. Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells. Nature 2007;449: Mizutari K, Fujioka M, Hosoya M, Bramhall N, Okano HJ, Okano H, et al. Notch inhibition induces cochlear hair cell regeneration and recovery of hearing after acoustic trauma. Neuron 2013;77: Lentz JJ, Jodelka FM, Hinrich AJ, McCaffrey KE, Farris HE, Spalitta MJ, et al. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat Med 2013;19:
G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics
G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics One of every 500 newborns has bilateral permanent sensorineural hearing loss 40 db which makes it the most common
More informationCorporate Medical Policy Genetic Testing for Hereditary Hearing Loss
Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_hereditary_hearing_loss 10/2013 8/2015 8/2016
More informationTitle: Genetics and Hearing Loss: Clinical and Molecular Characteristics
Session # : 46 Day/Time: Friday, May 1, 2015, 1:00 4:00 pm Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics Presenter: Kathleen S. Arnos, PhD, Gallaudet University This presentation
More informationThe Genetics of Hearing Loss. Heidi L. Rehm, Ph.D. Harvard Medical School Boston, MA
The Genetics of Hearing Loss Heidi L. Rehm, Ph.D. Harvard Medical School Boston, MA Faculty Disclosure Information In the past 12 months, I have not had a significant financial interest or other relationship
More informationPatient Information. for Childhood
Patient Information Genetic Testing for Childhood Hearing Loss Introduction This document describes the most common genetic cause of childhood hearing loss and explains the role of genetic testing. Childhood
More informationGenetic Testing for Hereditary Hearing Loss
MEDICAL POLICY POLICY RELATED POLICIES POLICY GUIDELINES DESCRIPTION SCOPE BENEFIT APPLICATION RATIONALE REFERENCES CODING APPENDIX HISTORY Genetic Testing for Hereditary Hearing Loss Number 12.04.87 Effective
More informationJennifer A. Defant, M.S., C.G.C. Certified Genetic Counselor Division of Genetics and Metabolism University of Florida
Jennifer A. Defant, M.S., C.G.C. Certified Genetic Counselor Division of Genetics and Metabolism University of Florida 60% of childhood hearing loss is genetic Syndromic Nonsyndromic 40% of childhood hearing
More informationA bout 1 in 1000 British children are born deaf.
1of5 ELECTRONIC LETTER Genetic information but not termination: pregnant women s attitudes and willingness to pay for carrier screening for deafness genes M Ryan, Z Miedzybrodzka, L Fraser, M Hall... J
More informationObjectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL
Objectives Role of Medical Genetics in Hearing Loss Evaluation Millan Patel, MD UBC Dept. of Medical Genetics October 22, 2010 Case presentation to illustrate importance of defining syndromic hearing loss
More informationGenetic Testing for Hereditary Hearing Loss. Populations Interventions Comparators Outcomes Interventions of interest are: Genetic testing
Protocol Genetic Testing for Hereditary Hearing Loss (20487) Medical Benefit Effective Date: 01/01/15 Next Review Date: 11/16 Preauthorization Yes Review Dates: 01/14, 11/14, 11/15 Preauthorization is
More informationAbout The Causes of Hearing Loss
About 1 in 500 infants is born with or develops hearing loss during early childhood. Hearing loss has many causes: some are genetic (that is, caused by a baby s genes) or non-genetic (such as certain infections
More informationGenetic Testing for Hearing Loss
Genetic Testing for Hearing Loss S H O B A N A K U B E N D R A N, M B B S, M S, C G C G E N E T I C C O U N S E L O R A S S T P R O F E S S O R D E P T O F P E D I A T R I C S K U S M - W Objectives Indications
More informationMedical Policy Genetic Testing for Hereditary Hearing Loss
Medical Policy Genetic Testing for Hereditary Hearing Loss Table of Contents Policy: Commercial Coding Information Information Pertaining to All Policies Policy: Medicare Description References Authorization
More informationUsher Syndrome Genetics
Usher Syndrome Genetics October 2012 Page 1 of 20 Introduction Usher syndrome is a genetic or inherited condition that affects hearing, vision and balance The sight loss is caused by an eye condition known
More informationMolecular Genetic Testing in Public Health and Clinical Settings
Molecular Genetic Testing in Public Health and Clinical Settings Ira M. Lubin, PhD, FACMG Division of Laboratory Systems NCPDCID, CCID Centers for Disease Control and Prevention Atlanta, Georgia Disclaimers
More informationGenetic Bases of Hearing Loss: Future Treatment Implications
Genetic Bases of Hearing Loss: Future Treatment Implications Luis F. Escobar, MD Medical Director Medical Genetics & Neurodevelopmental Pediatrics of Indiana Peyton Manning Children s Hospital St. Vincent
More informationSingle Gene and NextGen Panels
Molecular Testing for Hearing Loss: Single Gene and NextGen Panels Honey V Reddi, PhD, FACMG Clinical Molecular Geneticist Prevention Genetics, Marshfield, WI www.preventiongenetics.com Outline of Presentation
More informationDURATION OF HEARING LOSS
When your child is diagnosed with a hearing loss, it may be very overwhelming. This may be a difficult time for you and your family. However, gaining a greater knowledge in this area is crucial in helping
More informationGenetic Mutations Cause Many Birth Defects:
Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project Jan M. Friedman, MD, PhD University it of British Columbia Vancouver, Canada I have no conflicts of interest related
More informationMedical Policy Manual. Date of Origin: October 2014. Topic: Genetic Testing for Hereditary Hearing Loss. Last Reviewed Date: December 2015
Medical Policy Manual Topic: Genetic Testing for Hereditary Hearing Loss Section: Genetic Testing Policy No: 36 Date of Origin: October 2014 Last Reviewed Date: December 2015 Effective Date: February 1,
More informationBEST PRACTICES Pediatric Bilateral Sensorineural Hearing Loss
BEST PRACTICES Pediatric Bilateral Sensorineural Hearing Loss Christina L. Runge, PhD, CCC-A Associate Professor Chief, Division of Communication Sciences Director, Koss Cochlear Implant Program Resources
More informationCorporate Medical Policy Genetic Testing for Fanconi Anemia
Corporate Medical Policy Genetic Testing for Fanconi Anemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_fanconi_anemia 03/2015 3/2016 3/2017 3/2016 Description
More informationRare Diseases: Genetic Testing and Targeted Therapy
Rare Diseases: Genetic Testing and Targeted Therapy Meral Özgüç Hacettepe University Faculty of Medicine Department of Medical Biology & DNA/Cell Bank RDs Definition! Low prevalence (Less than 5/10000)!
More informationCONGENITAL HEARING LOSS
CONGENITAL HEARING LOSS Congenital hearing loss, for the purposes of this fact sheet, is defined as permanent and is bilateral or unilateral, is sensory or conductive, and averages 30 db or more in the
More informationVictims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
More informationSo, how do we hear? outer middle ear inner ear
The ability to hear is critical to understanding the world around us. The human ear is a fully developed part of our bodies at birth and responds to sounds that are very faint as well as sounds that are
More informationThe future role of genetic screening to detect newborns at risk of childhood-onset hearing loss
International Journal of Audiology 2013; 52: 124 133 Discussion Article The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss Luan Linden Phillips *, Maria Bitner-Glindzicz,
More informationAttitudes of Deaf Adults toward Genetic Testing for Hereditary Deafness
Am. J. Hum. Genet. 63:1175 1180, 1998 Attitudes of Deaf Adults toward Genetic Testing for Hereditary Deafness Anna Middleton, 1 J. Hewison, 2 R. F. Mueller 1 1 Department of Clinical Genetics, St. James
More informationCochlear Implantation for Children With GJB2-Related Deafness
The Laryngoscope Lippincott Williams & Wilkins, Inc. 2004 The American Laryngological, Rhinological and Otological Society, Inc. Cochlear Implantation for Children With GJB2-Related Deafness Robert D.
More informationGoals for Today. Clinical and Molecular Aspects of Genetic Hearing Loss. Case presentation. Case presentation continued. Case presentation continued
Clinical and Molecular Aspects of Genetic Hearing Loss Kathleen Arnos, PhD Department of Science, Technology, & Mathematics Gallaudet University Washington, DC 20002 kathleen.arnos@gallaudet.edu Goals
More informationGenetic Aspects of Mental Retardation and Developmental Disabilities
Prepared by: Chahira Kozma, MD Associate Professor of Pediatrics Medical Director/DCHRP Kozmac@georgetown.edu cck2@gunet.georgetown.edu Genetic Aspects of Mental Retardation and Developmental Disabilities
More informationcommentary Genetics IN Medicine 521 November/December 2004 Vol. 6 No. 6
November/December 2004 Vol. 6 No. 6 commentary Genetic testing as part of the Early Hearing Detection and Intervention (EHDI) process Lisa A. Schimmenti, MD 1, Ariadna Martinez, MS, MS 2, Michelle Fox,
More informationGenetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
More informationSupervisors Prof.Dr.Ahmad Sameh Farid Professor of ENT and Audiology Faculty of Medicine Cairo University
Connexin 26 gene in non-syndromic hearing loss Thesis Submitted for partial fulfillment of MD degree in Audiology by Mona Ahmed El-Akkad M.B, B.CH., MSc. Supervisors Prof.Dr.Ahmad Sameh Farid Professor
More information1/26/2011. 50% of deafness and hearing impairment is avoidable through prevention, early diagnosis, and management.
Hearing Impairment Roseann Mulligan, DDS, MS Herman Ostrow School of Dentistry of the University of Southern California 1 JAMA, July 4, 2007 Vol 298, No. 1 2 278 million - moderate to profound bilateral
More informationDiagnostic Scoring System for LQTS
Medical Coverage Policy Genetic Testing: Congenital Long QT Syndrome Device/Equipment Drug Medical Surgery Test Other Effective Date: 2/15/2011 Policy Last Updated: 2/21/2012 Prospective review is recommended/required.
More informationUNIT 13 (OPTION) Genetic Abnormalities
Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty
More informationDeafness and Hereditary Hearing Loss Overview
Page 1 of 25 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviews [Internet]. Seattle (WA): University
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance Program (CMAP) on the requirements for
More informationGONCA SENNAROĞLU PhD LEVENT SENNAROĞLU MD. Department of Otolaryngology Hacettepe University ANKARA, TURKEY
GONCA SENNAROĞLU PhD LEVENT SENNAROĞLU MD Department of Otolaryngology Hacettepe University ANKARA, TURKEY To present the audiological findings and rehabilitative outcomes of CI in children with cochlear
More informationPreimplantation Genetic Diagnosis. Evaluation for single gene disorders
Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of
More informationHow To Identify A Novel Pathway Leading To Myocardial Infarction
Press Release Embargo: 10 November 2013 at 1800 London time / 1300 US Eastern Time Genetic research identifies novel pathway leading to myocardial infarction Starting with a severely affected family, a
More informationWhat Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives
What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What does the career involve? Explore family histories to identify risks Reducing risks
More informationGenetics of Hearing Loss
2 Genetics of Hearing Loss Ella Shalit and Karen B. Avraham 1. Introduction The revolution in genetics in the past decades has enabled identification of many of the genes associated with human hereditary
More informationREQUEST FOR IMAGe SYNDROME TESTING
REQUEST FOR IMAGe SYNDROME TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST
More informationWhy does my child have a hearing loss?
Introduction This factsheet will tell you about the range of tests that can be carried out to try to find the cause of your child s hearing loss. The process to find out why a child is deaf is sometimes
More informationSTEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.
STEM CELL FACTS The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine. WHAT ARE STEM CELLS? Stem cells are the foundation cells for
More informationDelivering the power of the world s most successful genomics platform
Delivering the power of the world s most successful genomics platform NextCODE Health is bringing the full power of the world s largest and most successful genomics platform to everyday clinical care NextCODE
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationMuscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy
Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy pathology: muscle fiber degeneration and regeneration Muscular
More informationObstetrical Ultrasound and Prenatal Diagnostic Center
Obstetrical Ultrasound and Prenatal Diagnostic Center Prenatal Diagnosis: Options and Opportunities Learn about various screening options including Early Risk Assessment (ERA), now available to women of
More informationCommon Cancers & Hereditary Syndromes
Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.
More informationUnderstanding the Genetics of Deafness
Understanding the Genetics of Deafness A Guide for Patients and Families Harvard Medical School Center For Hereditary Deafness Understanding the Genetics of Deafness Understanding the Genetics of Deafness
More informationplaque reduction assay, modified dye uptake assay including formazan test, dye uptake assay
Sauerbrei A, Bohn-Wippert K, Kaspar M, Krumbholz A, Karrasch M, Zell R. 2015. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes
More informationSpinal Muscular Atrophy
Maryam Oskoui, MD, MSc, FRCPC Pediatric Neurologist Spinal Muscular Atrophy Elise Historical Timeline In vitro and animal studies Werdnig and Hoffmann describe SMA 1 (Arch Psych Nervenkrankheiten) Disease
More informationGene mutation and molecular medicine Chapter 15
Gene mutation and molecular medicine Chapter 15 Lecture Objectives What Are Mutations? How Are DNA Molecules and Mutations Analyzed? How Do Defective Proteins Lead to Diseases? What DNA Changes Lead to
More informationSpeech-Language Pathology Curriculum Foundation Course Linkages
FACULTY OF HEALTH PROFESSIONS School of Human Communication Disorders Speech-Language Pathology Curriculum Foundation Course Linkages Phonetics (HUCD 5020) a. Vowels b. Consonants c. Suprasegmentals d.
More informationThe RNA strategy. RNA as a tool and target in human disease diagnosis and therapy.
The RNA strategy RNA as a tool and target in human disease diagnosis and therapy. The Laboratory of RNA Biology and Biotechnology at the Centre for Integrative Biology (CIBIO) of the University of Trento,
More informationHearing loss is an etiologically heterogeneous trait with
The new england journal of medicine review article Current Concepts Newborn Hearing Screening A Silent Revolution Cynthia C. Morton, Ph.D., and Walter E. Nance, M.D., Ph.D. Hearing loss is an etiologically
More informationNORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1
NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle
More informationPrevention GENEration. The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC)
הסיכוי שבסיכון PREVENTION GENERATION Prevention GENEration The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC) We thank Prof. Ephrat Levy-Lahad Director, Medical
More informationInformation leaflet. Centrum voor Medische Genetica. Version 1/20150504 Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel
Information on genome-wide genetic testing Array Comparative Genomic Hybridization (array CGH) Single Nucleotide Polymorphism array (SNP array) Massive Parallel Sequencing (MPS) Version 120150504 Design
More informationEssential Nursing Competencies and Curricula Guidelines for Genetics and Genomics: Outcome Indicators
Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics: Outcome Indicators Introduction The Outcome Indicators are an adjunct to the Essential Nursing Competencies and Curricula
More informationLecture 3: Mutations
Lecture 3: Mutations Recall that the flow of information within a cell involves the transcription of DNA to mrna and the translation of mrna to protein. Recall also, that the flow of information between
More informationLeading Genomics. Diagnostic. Discove. Collab. harma. Shanghai Cambridge, MA Reykjavik
Leading Genomics Diagnostic harma Discove Collab Shanghai Cambridge, MA Reykjavik Global leadership for using the genome to create better medicine WuXi NextCODE provides a uniquely proven and integrated
More informationDIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES
DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES Extracts from a review article by KN North and KJ Jones: Recent advances in diagnosis of the childhood muscular dystrophies Journal of Paediatrics and Child Health
More informationPreimplantation Genetic Diagnosis (PGD) and Childhood Diagnostic Evaluation
IG O Preimplantation Genetic Diagnosis (PGD) and Childhood Diagnostic Evaluation KD Carsten Bergmann carsten.bergmann@bioscientia.de carsten.bergmann@uniklinik-freiburg.de Controversies Conference on ADPKD
More informationClinical Policy Title: Genomic tests in sensorineural hearing loss
Clinical Policy Title: Genomic tests in sensorineural hearing loss Clinical Policy Number: 02.01.18 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent Review Date: September
More informationEnlarged Vestibular Aqueduct Syndrome
PO BOX 13305 PORTLAND, OR 97213 FAX: (503) 229-8064 (800) 837-8428 INFO@VESTIBULAR.ORG WWW.VESTIBULAR.ORG Enlarged Vestibular Aqueduct Syndrome (EVAS) By Hamid, MD, PhD, EE, The Cleveland Hearing & Balance
More informationCracking the DNA Code: Genetic Testing Case Examples of Interest to Elder Law and Special Needs Planning Attorneys
Fall 2015 103 Cracking the DNA Code: Genetic Testing Case Examples of Interest to Elder Law and Special Needs Planning Attorneys By Kelli Swan, MS, and Jaellah S. Thalberg, MS I. Introduction... 104 II.
More informationThe following chapter is called "Preimplantation Genetic Diagnosis (PGD)".
Slide 1 Welcome to chapter 9. The following chapter is called "Preimplantation Genetic Diagnosis (PGD)". The author is Dr. Maria Lalioti. Slide 2 The learning objectives of this chapter are: To learn the
More informationSurvey on infant hearing loss at Caritas Baby Hospital in Bethlehem-Palestine
Audiology Research 2014; volume 4:99 Survey on infant hearing loss at Caritas Baby Hospital in Bethlehem-Palestine Lucia Corradin, 1 Musa Hindiyeh, 1 Rasha Khaled, 1 Fadi Rishmawi, 1 Marwan Zidan, 2 Hiyam
More informationCongenital Deafness and Goiter: Pendred Syndrome
This text is a translation from the original German which should be used for referencing. The German version is authoritative. REVIEW ARTICLE Congenital Deafness and Goiter: Pendred Syndrome Guntram Borck,
More informationCONNEXINS IN HEARING LOSS: A COMPREHENSIVE OVERVIEW
CONNEXINS IN HEARING LOSS: A COMPREHENSIVE OVERVIEW Adi D. Sabag, Orit Dagan and Karen B. Avraham Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel
More informationGenetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -
Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - January 2005 SCIENTIFIC BACKGROUND Breast cancer is considered to be one of the most prevalent cancer in women. The overall
More informationBRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?
BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? Giovanni Luca Scaglione, PhD ------------------------ Laboratory of Clinical Molecular Diagnostics and Personalized Medicine, Institute
More informationEXECUTIVE SUMMARY OF JOINT COMMITTEE ON INFANT HEARING YEAR 2007 POSITION STATEMENT. Intervention Programs
EXECUTIVE SUMMARY OF JOINT COMMITTEE ON INFANT HEARING YEAR 2007 POSITION STATEMENT Principles and Guidelines for Early Hearing Detection and Intervention Programs The Joint Committee on Infant Hearing
More informationRoberto Ciccone, Orsetta Zuffardi Università di Pavia
Roberto Ciccone, Orsetta Zuffardi Università di Pavia XIII Corso di Formazione Malformazioni Congenite dalla Diagnosi Prenatale alla Terapia Postnatale unipv.eu Carrara, 24 ottobre 2014 Legend:Bluebars
More informationAGE Iowa Midwest Nation N % N % N % Total students 256 100.0 9272 100.0 37500 100.0 Information NOT reported 7 2.7 229 2.5 841 2.2
202-651-5575 * 1-800-451-8834 ext 5575 Page 1 of 9 AGE Iowa Midwest Nation Information NOT reported 7 2.7 229 2.5 841 2.2 Total known information 249 100.0 9043 100.0 36659 100.0 Under 3 years 16 6.4 201
More informationHuman Genome Organization: An Update. Genome Organization: An Update
Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion
More informationThe NeurOmics team at a recent project meeting
Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work
More informationBioBoot Camp Genetics
BioBoot Camp Genetics BIO.B.1.2.1 Describe how the process of DNA replication results in the transmission and/or conservation of genetic information DNA Replication is the process of DNA being copied before
More informationDeafblind syndromes, diagnostic tools and treatment
Deafblind syndromes, diagnostic tools and treatment Claes Möller Department of Audiology Örebro University Hospital Confusion Why is my child deaf? Why is my child clumsy? Why has my child problems at
More informationTHE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationInnovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
More informationHEARING & HEARING LOSS. Dr I Butler 2015
HEARING & HEARING LOSS Dr I Butler 2015 DISCLOSURE Sponsorship to attend local and international workshops Cochlear (Southern ENT) Med el TOPICS Anatomy Classification of hearing loss Congenital hearing
More informationThe Developing Person Through the Life Span 8e by Kathleen Stassen Berger
The Developing Person Through the Life Span 8e by Kathleen Stassen Berger Chapter 3 Heredity and Environment PowerPoint Slides developed by Martin Wolfger and Michael James Ivy Tech Community College-Bloomington
More informationDisease gene identification with exome sequencing
Disease gene identification with exome sequencing Christian Gilissen Dept. of Human Genetics Radboud University Nijmegen Medical Centre c.gilissen@antrg.umcn.nl Contents Infrastructure Exome sequencing
More informationCOCHLEAR IMPLANTATION IN A PATIENT WITH LARGE VESTIBULAR AQUEDUCT SYNDROME: A CASE REPORT GENİŞ VESTİBÜLER SENDROMLU HASTADA KOKLEAR İMPLANTASYON
CASE REPORT COCHLEAR IMPLANTATION IN A PATIENT WITH LARGE VESTIBULAR AQUEDUCT SYNDROME: A CASE REPORT Ufuk Derinsu, Ayça Çiprut, Sezer Külekçi, Ferda Akdaş Sub-department of Audiology, Department of Otorhinolaryngology,
More informationPrevalence of otological disorders in diabetic patients with hearing loss
Prevalence of otological disorders in diabetic patients with hearing loss Manche Santoshi Kumari *, Jangala Madhavi *, Koralla Raja Meganadh *, Akka Jyothy Institute of Genetics and Hospital for Genetic
More informationHow To Understand How Gene Expression Is Regulated
What makes cells different from each other? How do cells respond to information from environment? Regulation of: - Transcription - prokaryotes - eukaryotes - mrna splicing - mrna localisation and translation
More informationBI122 Introduction to Human Genetics, Fall 2014
BI122 Introduction to Human Genetics, Fall 2014 Course Overview We will explore 1) the genetic and molecular basis of heredity and inherited traits, 2) how genetics & genomics reveals an understanding
More informationGenetic diagnostics the gateway to personalized medicine
Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed
More informationGENETIC TESTING AND MARFAN SYNDROME
GENETIC TESTING AND MARFAN SYNDROME Genetic testing for mutations in fibrillin-1 (FBN1) and other genes has become an important and reliable option to aid in the diagnosis of Marfan syndrome and related
More informationHuman Cloning The Science and Ethics of Nuclear Transplantation
Human Cloning The Science and Ethics of Transplantation Rudolf Jaenisch, M.D. In addition to the moral argument against the use of somatic-cell nuclear for the creation of a child ( reproductive cloning
More informationCongenital Hearing Loss
Congenital Hearing Loss A resident asks... Why would a primary care physician want to know about the genetics of hearing loss? Key Points: Newborn screening for hearing loss is being implemented in many
More informationA Common Genetic Disorder Deafness
A Common Genetic Disorder Deafness Shahid Hussain Department of Bioinformatics, Mohammad Ali Jinnah University Islamabad, Pakistan Abstract: Deafness is a complete or partial loss of hearing, caused due
More informationMinimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics January 2006 1. BACKGROUND ICSI has been shown to be effective for male factor infertility and it also
More informationNOVEL FOXC2 MISSENSE MUTATION IDENTIFIED IN PATIENT WITH LYMPHEDEMA-DISTICHIASIS SYNDROME AND REVIEW
98 Lymphology 41 (2008) 98-102 NOVEL FOXC2 MISSENSE MUTATION IDENTIFIED IN PATIENT WITH LYMPHEDEMA-DISTICHIASIS SYNDROME AND REVIEW M.T. Dellinger, K. Thome, M.J. Bernas, R.P. Erickson, M.H. Witte Departments
More informationCarrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner)
Carrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner) The goal of our practice at ARMS is to make sure that you receive optimal care to improve your chances of having
More information